Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic

Z Wang, K Cui, U Costabel, X Zhang - Exploration, 2022 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) continually poses a significant threat to the
human race, and prophylactic vaccination is the most potent approach to end this pandemic …

Chemical and biological conjugation strategies for the development of multivalent protein vaccine nanoparticles

J Park, T Pho, JA Champion - Biopolymers, 2023 - Wiley Online Library
The development of subunit vaccine platforms has been of considerable interest due to their
good safety profile and ability to be adapted to new antigens, compared to other vaccine …

Nanovaccines against animal pathogens: The latest findings

CT Celis-Giraldo, J López-Abán, A Muro, MA Patarroyo… - Vaccines, 2021 - mdpi.com
Nowadays, safe and efficacious vaccines represent powerful and cost-effective tools for
global health and economic growth. In the veterinary field, these are undoubtedly key tools …

Self-assembling peptides and carbon nanomaterials join forces for innovative biomedical applications

P Rozhin, C Charitidis, S Marchesan - Molecules, 2021 - mdpi.com
Self-assembling peptides and carbon nanomaterials have attracted great interest for their
respective potential to bring innovation in the biomedical field. Combination of these two …

Bacteriophage P22 capsid as a pluripotent nanotechnology tool

VA Essus, GS Souza Júnior, GHP Nunes, JS Oliveira… - Viruses, 2023 - mdpi.com
The Salmonella enterica bacteriophage P22 is one of the most promising models for the
development of virus-like particle (VLP) nanocages. It possesses an icosahedral T= 7 …

The role of nucleoprotein in immunity to human negative-stranded RNA viruses—not just another brick in the viral nucleocapsid

M Šantak, Z Matić - Viruses, 2022 - mdpi.com
Negative-stranded RNA viruses (NSVs) are important human pathogens, including
emerging and reemerging viruses that cause respiratory, hemorrhagic and other severe …

Respiratory syncytial virus infection: treatments and clinical management

S Malik, T Ahmad, K Muhammad, Y Waheed - Vaccines, 2023 - mdpi.com
Respiratory syncytial virus (RSV) is a major healthcare concern, especially for immune-
compromised individuals and infants below 5 years of age. Worldwide, it is known to be …

Nanomedicine approaches against SARS-CoV-2 and variants

H Zhang, Y Liu, Z Liu - Journal of Controlled Release, 2024 - Elsevier
The world is grappling with the ongoing crisis of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), a global pandemic that continues to have a detrimental …

T Cell Activating Thermostable Self‐Assembly Nanoscaffold Tailored for Cellular Immunity Antigen Delivery

J Zhang, J Yang, Q Li, R Peng, S Fan, H Yi… - Advanced …, 2023 - Wiley Online Library
Antigen delivery based on non‐virus‐like particle self‐associating protein nanoscffolds,
such as Aquifex aeolicus lumazine synthase (AaLS), is limited due to the immunotoxicity …

Viral Nanoparticles‐Mediated Delivery of Therapeutic Cargo

S Zanganeh, M Doroudian, ZR Nowzari… - Advanced …, 2023 - Wiley Online Library
The rapid advancement of nanotechnology in recent years has opened new avenues of
investigation for biomedical sciences. Viral nanoparticles (VNPs) are formulated from plant …